Filing Details

Accession Number:
0001209191-15-080796
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-11-17 21:45:14
Reporting Period:
2015-11-17
Filing Date:
2015-11-17
Accepted Time:
2015-11-17 21:45:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1479290 Revance Therapeutics Inc. RVNC Pharmaceutical Preparations (2834) 770551645
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1426344 Peter Arthur Bertolino C/O Revance Therapeutics, Inc.
7555 Gateway Boulevard
Newark CA 94560
Evp And Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-11-17 5,425 $39.11 36,329 No 4 S Direct
Common Stock Disposition 2015-11-17 36 $39.55 36,293 No 4 S Direct
Common Stock Disposition 2015-11-17 2,277 $39.11 34,016 No 4 S Direct
Common Stock Disposition 2015-11-17 15 $39.55 34,001 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The Reporting Person sold an aggregate of 5,461 shares of restricted stock to settle a personal tax liability in connection with the November 15, 2015 vesting of certain shares of restricted stock that the Reporting Person acquired pursuant to a grant dated September 2, 2014.
  2. The Reporting Person sold an aggregate of 2,292 shares of restricted stock to settle a personal tax liability in connection with the November 15, 2015 vesting of certain shares of restricted stock that the Reporting Person acquired pursuant to a grant dated January 28, 2015.